[go: up one dir, main page]

NO811721L - R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape - Google Patents

R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape

Info

Publication number
NO811721L
NO811721L NO811721A NO811721A NO811721L NO 811721 L NO811721 L NO 811721L NO 811721 A NO811721 A NO 811721A NO 811721 A NO811721 A NO 811721A NO 811721 L NO811721 L NO 811721L
Authority
NO
Norway
Prior art keywords
coating
pharmaceutical preparation
release property
improved release
active substance
Prior art date
Application number
NO811721A
Other languages
English (en)
Inventor
Conny Boerje
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20341009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO811721(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO811721L publication Critical patent/NO811721L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Oralt farmasøytisk preparat omfattende en kjerne inneholdende terapeutisk aktivt stoff og et belegg, idet belegget omfatter en anionisk karboksyl-akryl polymer opplselig bare over pH 5,5, i en mengde på 10 - 85 vekt% av belegget, og en vannuoppløselig polymer valgt blant kvarternær ammonium substituert akryl polymer. Preparatet muliggjør frigjøring av hoveddelen av det aktive stoffinnholdet i den nedre del av fordøyelsessystemet.
NO811721A 1980-05-21 1981-05-20 R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape NO811721L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Publications (1)

Publication Number Publication Date
NO811721L true NO811721L (no) 1981-11-23

Family

ID=20341009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811721A NO811721L (no) 1980-05-21 1981-05-20 R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape

Country Status (9)

Country Link
EP (1) EP0040590A3 (no)
DK (1) DK221281A (no)
ES (1) ES8301630A1 (no)
GR (1) GR75634B (no)
NO (1) NO811721L (no)
PH (1) PH16539A (no)
PT (1) PT73065B (no)
SE (1) SE8003805L (no)
ZA (1) ZA813017B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
CA2320193A1 (en) 1998-02-10 1999-08-19 Welfide Corporation Controlled release preparation
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2003269741A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
CA2557848C (en) 2004-03-30 2013-12-10 Ilypsa, Inc. Ion binding compositions
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
SG164375A1 (en) * 2004-08-13 2010-09-29 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
EP2231122A1 (en) * 2008-01-10 2010-09-29 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
US9011907B2 (en) 2008-01-10 2015-04-21 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
CN102238868A (zh) 2008-10-03 2011-11-09 福尔克博士药物有限责任公司 使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
FR3102931B1 (fr) 2019-11-13 2021-12-24 Ethypharm Sa Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique
CN115461046A (zh) 2019-11-13 2022-12-09 爱的发制药集团 用于生产具有结肠递送的口服施用药物组合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1297719A (no) * 1970-06-11 1972-11-29
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung

Also Published As

Publication number Publication date
ES502345A0 (es) 1982-12-16
DK221281A (da) 1981-11-22
ES8301630A1 (es) 1982-12-16
ZA813017B (en) 1982-05-26
PT73065A (en) 1981-06-01
GR75634B (no) 1984-08-01
PT73065B (en) 1983-02-08
SE8003805L (sv) 1981-11-22
PH16539A (en) 1983-11-10
EP0040590A2 (en) 1981-11-25
EP0040590A3 (en) 1983-01-12

Similar Documents

Publication Publication Date Title
NO811721L (no) R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape
DE69622510D1 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
DE3855852D1 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
SE7906119L (sv) Lekemedel-retardform med olosliga porosa diffusionsholjen
DK400685D0 (da) Praeparat med kontrolleret afgivelse
YU22794A (sh) Veterinarska kompozicija
TR199800121T1 (xx) Uzat�lm�� etki s�resine sahip ipratropyumbromid'in bir enantiyomeri.
MY101593A (en) Sustained release preparation.
ATE286724T1 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
OA07628A (fr) Résinate d'un acide carboxylique substitué, procédés pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
ATE380022T1 (de) Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
ATE244004T1 (de) Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung
RU94046268A (ru) Микрогранулы омепразола и способ их получения
KR860000865A (ko) 약제 제형의 제조방법
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
PT71495A (fr) Procede d'obtention d'extraits de lierre grimpant et de compositions pharmaceutiques qui en contiennent
PT72397B (en) Process for the preparation of n,n-dialkyl-o-(pyrazol-5-yl) carbanic acid derivatives and insecticide and nematicide compositions thereof
JPS649205A (en) Fixer composition, organic polymer for fixer, coating supporter and manufacture
NZ189212A (en) 3-amino substituted 1,5-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
TW289733B (en) Process for preparing round pellets of Omeprazole for oral administration
JPS6422824A (en) Antifungal agent
ES457496A1 (es) Procedimiento para la obtencion de una composicion pulveru- lenta e hidrosoluble de sulfamidina y pirimetamina.
JPS5231119A (en) Imitated animal hairlike synthetic fibers
PH14155A (en) Pharmaceutical compositions containing racemic or optically active 1-(2',6'-dimethyl-phenoxy)-2-methylaminopropane and method of use
JPS5770861A (en) N,n'-bis(5-oxo-1-methyl-pyrrolidine-2-yl-acetic acid)-hydrazide, manufacture and medicinal composition